Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a common drug reveal Parkinson's before symptoms start?

NCT ID NCT04386317

First seen Mar 28, 2026 · Last updated Jun 18, 2026 · Updated 15 times

Summary

This study looks at whether terazosin, a drug used for high blood pressure, can change heart nerve activity in people at high risk for Parkinson's disease. Researchers are studying 15 adults with REM sleep behavior disorder (a strong early sign of Parkinson's) to see if the drug affects heart scans and relates to symptom changes. The goal is to learn more about the earliest stages of Parkinson's, not to treat or cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REM SLEEP BEHAVIOR DISORDER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Michele L Lima Gregorio

    Los Angeles, California, 90046, United States

Conditions

The condition(s) this trial relates to.

Parkinson disease REM sleep behavior disorder secondary Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.